Asset icon - trade crypto, stocks, and gold on Pluang
Trade on Pluang
One platform for all markets
Download
Investment
Features
FeesSafety
Academy
More
Pluang+

Terex reports Q1 sales up 41%, adjusted EPS $0.98, and confirms 2026 sales and EBITDA growth outlook.

Company Fundamentals
01 May 2026
PRNewsWire
View Source
Neutral
pluang ai news

Terex Corporation reported a 41% increase in Q1 2026 sales to $1.7 billion, with adjusted EPS from continuing operations at $0.98, despite a GAAP loss due to merger-related charges. The company’s backlog rose to $7.1 billion, supporting strong forward visibility. Terex reaffirmed its 2026 outlook, expecting sales between $7.5 billion and $8.1 billion and EBITDA of $930 million to $1 billion, driven by integration synergies and growth across segments. The Specialty Vehicles segment, added through the REV Group acquisition, contributed positively, and the company aims to achieve $75 million in annual synergies within two years.

More News

Goodfirms releases 2026 tech vendor rankings based on 1.2M+ verified reviews across six key categories.

Goodfirms releases 2026 tech vendor rankings based on 1.2M+ verified reviews across six key categories.

Goodfirms has published its 2026 rankings of top technology service providers across six categories: mobile app, software, web development, digital marketing, SEO, and AI development. These rankings are based on over 1.2 million verified client revie...

Others
Neutral
1 hour ago
Alvotech prices $152M share offering and private placement to fund biosimilar development

Alvotech prices $152M share offering and private placement to fund biosimilar development

Alvotech announced a $152 million public offering and concurrent private placement of ordinary shares priced at $3.75 each. The public offering includes 22.7 million shares, with an option for underwriters to buy an additional 3.4 million shares. The...

Company Fundamentals
Bullish
1 hour ago
Alvotech prices $152M share offering in US and Europe to fund biotech drug development.

Alvotech prices $152M share offering in US and Europe to fund biotech drug development.

Alvotech announced pricing and allocation of a $152 million public share offering in the US and a concurrent private placement in Europe at $3.75 per share. The company expects total proceeds up to $165 million if underwriters exercise their full opt...

Company Fundamentals
Bullish
1 hour ago
Oxford Industries faces fraud investigation after revenue guidance cut triggers share drop

Oxford Industries faces fraud investigation after revenue guidance cut triggers share drop

The Schall Law Firm has launched an investigation into Oxford Industries following the company's sharp revenue guidance cut on June 10, 2026, which caused a significant drop in its share price. The probe focuses on whether Oxford issued false or misl...

Market News
Bearish
2 hours ago
Global highway, street, and bridge construction market to reach $2.18T by 2035, growing at 4.8% CAGR.

Global highway, street, and bridge construction market to reach $2.18T by 2035, growing at 4.8% CAGR.

The global market for highway, street, and bridge construction is projected to grow from $1.28 trillion in 2025 to $2.18 trillion by 2035, at a compound annual growth rate of 4.8%. Growth is driven by government infrastructure spending, urbanization,...

Market News
Neutral
3 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App